Multicenter Application Verification and Effect Evaluation of Artificial Intelligence-Based Snake Species Identification System in the Diagnosis and Treatment of Snakebites
Development, Validation and Clinical Efficacy Evaluation of an AI-based Snake Species Identification System for Snakebite Treatment: a Multicenter Prospective Observational Study
1 other identifier
observational
400
1 country
1
Brief Summary
This multicenter prospective observational study aims to develop and validate a deep learning-based artificial intelligence snake species identification system, and evaluate its clinical application efficacy in real-world emergency snakebite treatment scenarios. The primary research question it seeks to answer is: In real clinical settings in Zhejiang Province, can the artificial intelligence snake species identification system accurately identify common indigenous snake species causing bites, and improve the accuracy and diagnostic efficiency of snake species judgment for physicians at different levels of medical institutions? This study will be conducted simultaneously in 10 medical institutions in Zhejiang Province. investigators will prospectively enroll patients with snakebite who present to the hospital between June 2026 and December 2026 and can provide photographs of the offending snakes. The snake species identification results of both attending physicians and the artificial intelligence system will be recorded synchronously, and the patients' clinical treatment and prognosis data will be collected. All patients will be followed up until 30 days after discharge.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2026
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 5, 2026
CompletedStudy Start
First participant enrolled
June 20, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 20, 2026
CompletedFirst Posted
Study publicly available on registry
June 22, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
ExpectedJune 22, 2026
June 1, 2026
Same day
June 5, 2026
June 18, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Snake species identification (64-class classification) and venomous/non-venomous snake discrimination (binary classification)
From enrollment to the end of treatment at 30 days
Secondary Outcomes (2)
Consistency between physicians' judgments and AI results(%)
From enrollment to the end of treatment at 30 days
median time from hospital presentation to definitive snake species identification(hour)
72 hours
Interventions
Without interfering with clinical treatment, simultaneously record the physician's assessment and the identification results from the SSRS system.
Eligibility Criteria
All snakebite patients included in this study were recruited from medical institutions in snakebite-endemic areas, primarily county-level and prefecture-level hospitals.
You may qualify if:
- Adult patients aged ≥18 years, regardless of gender
- Definite history of snake bite, with time from bite occurrence to first medical visit ≤24 hours
- The patient or eyewitness can provide digital images of the biting snake (taken by mobile phone, camera, etc.)
- Voluntarily sign the written informed consent form; for patients with impaired consciousness who cannot sign independently, their legal representative shall sign on their behalf, and a secondary confirmation shall be obtained after the patient regains consciousness
- Able to cooperate in completing follow-up assessments at discharge and 30 days after injury
You may not qualify if:
- \. Unable to provide snake images, or images are severely blurred resulting in complete loss of key identification features 2. Snake species cannot be confirmed by the gold standard (no eyewitnesses, no typical clinical manifestations, cannot be clarified by expert panel consultation) 3. Medical visit exceeds 24 hours and the exact bite time and initial clinical manifestations cannot be determined 4. Complicated with end-stage malignant tumors, severe liver and kidney failure, or other underlying diseases that may significantly affect prognosis judgment 5. Refuse to sign the informed consent form or cannot cooperate in completing follow-up 6. Simultaneously participating in other clinical studies that may affect the results of this study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Second Affiliated Hospital, Zhejiang University School of Medicine
Hangzhou, Zhejiang, 310000, China
Related Publications (8)
Binta Islam S, Valles D, Hibbitts TJ, Ryberg WA, Walkup DK, Forstner MRJ. Animal Species Recognition with Deep Convolutional Neural Networks from Ecological Camera Trap Images. Animals (Basel). 2023 May 2;13(9):1526. doi: 10.3390/ani13091526.
PMID: 37174563RESULTZhang J, Chen X, Song A, Li X. Artificial intelligence-based snakebite identification using snake images, snakebite wound images, and other modalities of information: A systematic review. Int J Med Inform. 2023 May;173:105024. doi: 10.1016/j.ijmedinf.2023.105024. Epub 2023 Feb 24.
PMID: 36848781RESULTAga AM, Mulugeta D, Motuma A, Wakitole B, Muleta D, Ferede H, Teferi Z, Tadesse S, Abebe T, Alemayehu F, Dube D, Oljira S, Alemu A, Gebrewold G, Woldemariyam FT, Nigussie D. Health professionals' knowledge, attitudes, and practices in snakebite management: A study from high-burden areas in the Afar Region, Ethiopia. PLoS Negl Trop Dis. 2025 Nov 20;19(11):e0013713. doi: 10.1371/journal.pntd.0013713. eCollection 2025 Nov.
PMID: 41264600RESULTAbraham SV, Paul S, Mathew D, Rajeev PC, Paul MV, Davis C. Challenges in Snakebite Management in India: Insights from a Physician Survey with Special Focus on Kerala and treatment of bites by Hump-nosed Pit Vipers (Hypnale spp.). Wilderness Environ Med. 2025 Mar;36(1):76-88. doi: 10.1177/10806032241290800. Epub 2024 Nov 18.
PMID: 39552571RESULTRao S, Reghu N, Nair BG, Vanuopadath M. The Role of Snake Venom Proteins in Inducing Inflammation Post-Envenomation: An Overview on Mechanistic Insights and Treatment Strategies. Toxins (Basel). 2024 Dec 2;16(12):519. doi: 10.3390/toxins16120519.
PMID: 39728777RESULTShen Y, Hu S, Bao S, Tu M. Clinical characteristics of snakebite patients attending a tertiary hospital in Hangzhou, southeast China. Trans R Soc Trop Med Hyg. 2024 Apr 6;118(4):287-292. doi: 10.1093/trstmh/trad087.
PMID: 38073610RESULTYan S, Fu W, Yan Z, Hu Y, Song X, Wang J, Hao W, He L, Chen Y, Diane M, Souare IS, Guo W, Bin W, Ma Y, Han X, Lv C. Clinical epidemiology of snakebite envenoming in hospitals 11 provinces of Yangtze River Basin and southern regions of China: A retrospective hospital-based analysis. PLoS Negl Trop Dis. 2026 Apr 27;20(4):e0013247. doi: 10.1371/journal.pntd.0013247. eCollection 2026 Apr.
PMID: 42044109RESULTNyarko E, Atubiga IA, Siame ET, Gutierrez JM, Fernandez EA. Healthcare workers' priorities of WHO snakebite strategic objectives for the control and prevention of snakebite envenoming in Ghana: A machine learning statistical design of experiment modeling. PLoS Negl Trop Dis. 2025 Jul 10;19(7):e0013295. doi: 10.1371/journal.pntd.0013295. eCollection 2025 Jul.
PMID: 40638704RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Target Duration
- 30 Days
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 5, 2026
First Posted
June 22, 2026
Study Start
June 20, 2026
Primary Completion
June 20, 2026
Study Completion (Estimated)
December 31, 2026
Last Updated
June 22, 2026
Record last verified: 2026-06
Data Sharing
- IPD Sharing
- Will share
all IPD that underlie results in a publication